August 7, 2013 / 10:16 AM / 4 years ago

Valeant posts profit, raises 2013 outlook

1 Min Read

Aug 7 (Reuters) - Valeant Pharmaceuticals International Inc , Canada's biggest publicly traded drugmaker, raised its full-year adjusted profit outlook and reported a second-quarter profit, boosted by sales in its skincare acquisitions.

The company's net income was $10.9 million, or 3 cents per share, for the three months ended June compared with a loss of $21.6 million, or 7 cents, a year earlier.

Valeant raised its full-year forecast for adjusted profit, which it calls cash earnings, to $6.00-$6.20 per share from its prior estimate of $5.55-$5.85 per share.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below